Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...

A global contract development and manufacturing organization focused on drug-device combination products. The company operates across multiple sites in the U.S. and the U.K., including a U.K.

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the ...

Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced that it has manufactured Phase 2 clinical trial supplies for a dry powder inhalation (DPI) ...

Please provide your email address to receive an email when new articles are posted on . The ICoN-1 trial has been discontinued, and futility was the reason for this decision. The company is still ...

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced the submission of a new drug application (NDA) to the ...